1. Secreted Compounds of the Probiotic Bacillus clausii Strain O/C Inhibit the Cytotoxic Effects Induced by Clostridium difficile and Bacillus cereus Toxins
- Author
-
Philippe Bressollier, Maria C. Urdaci, Anne-Marie Elie, Claudine Jacquot, Silvia M. Racedo, Gabrielle Ripert, Chimie et Biologie des Membranes et des Nanoobjets (CBMN), Université de Bordeaux (UB)-École Nationale d'Ingénieurs des Travaux Agricoles - Bordeaux (ENITAB)-Institut de Chimie du CNRS (INC)-Centre National de la Recherche Scientifique (CNRS), Université de Limoges (UNILIM), PEIRENE (PEIRENE), Institut Génomique, Environnement, Immunité, Santé, Thérapeutique (GEIST), Université de Limoges (UNILIM)-Université de Limoges (UNILIM), Institut de biochimie et biophysique moléculaire et cellulaire (IBBMC), and Université Paris-Sud - Paris 11 (UP11)-Centre National de la Recherche Scientifique (CNRS)
- Subjects
0301 basic medicine ,Cell Survival ,medicine.medical_treatment ,Bacterial Toxins ,030106 microbiology ,Bacillus cereus ,Microbiology ,03 medical and health sciences ,chemistry.chemical_compound ,Intestinal mucosa ,Cell Line, Tumor ,Chlorocebus aethiops ,RhoB GTP-Binding Protein ,medicine ,Animals ,Humans ,[CHIM]Chemical Sciences ,Protease Inhibitors ,Pharmacology (medical) ,Subtilisins ,Intestinal Mucosa ,rhoB GTP-Binding Protein ,Mechanisms of Action: Physiological Effects ,Vero Cells ,Pharmacology ,Protease ,biology ,Clostridioides difficile ,Probiotics ,fungi ,Bacillus clausii ,Clostridium difficile ,biology.organism_classification ,3. Good health ,Phenylmethylsulfonyl Fluoride ,Infectious Diseases ,Biochemistry ,Cereus ,chemistry ,Culture Media, Conditioned ,Caco-2 Cells ,PMSF - Abstract
Although the use of probiotics based on Bacillus strains to fight off intestinal pathogens and antibiotic-associated diarrhea is widespread, the mechanisms involved in producing their beneficial effects remain unclear. Here, we studied the ability of compounds secreted by the probiotic Bacillus clausii strain O/C to counteract the cytotoxic effects induced by toxins of two pathogens, Clostridium difficile and Bacillus cereus , by evaluating eukaryotic cell viability and expression of selected genes. Coincubation of C. difficile and B. cereus toxic culture supernatants with the B. clausii supernatant completely prevented the damage induced by toxins in Vero and Caco-2 cells. The hemolytic effect of B. cereus was also avoided by the probiotic supernatant. Moreover, in these cells, the expression of rhoB , encoding a Rho GTPase target for C. difficile toxins, was normalized when C. difficile supernatant was pretreated using the B. clausii supernatant. All of the beneficial effects observed with the probiotic were abolished by the serine protease inhibitor phenylmethylsulfonyl fluoride (PMSF). Suspecting the involvement of a secreted protease in this protective effect, a protease was purified from the B. clausii supernatant and identified as a serine protease (M-protease; GenBank accession number Q99405 ). Experiments on Vero cells demonstrated the antitoxic activity of the purified protease against pathogen supernatants. This is the first report showing the capacity of a protease secreted by probiotic bacteria to inhibit the cytotoxic effects of toxinogenic C. difficile and B. cereus strains. This extracellular compound could be responsible, at least in part, for the protective effects observed for this human probiotic in antibiotic-associated diarrhea.
- Published
- 2016
- Full Text
- View/download PDF